后腹腔镜肾输尿管全切加腹膜后肾周区域淋巴结清扫与开放手术治疗UUT-TCC疗效比较

目的:探讨后腹腔镜技术与开放手术治疗上尿路移行细胞癌(upper urinary tract transitional cell carcinoma,UUT-TCC)的效果及优势。方法:回顾性分析2009年11月~2012年12月间,我院采用后腹腔镜下肾输尿管根治性切除术加腹膜后肾周区域淋巴结清扫术治疗肾盂输尿管癌患者23例(腹腔镜组),并与同期14例行传统开放性肾输尿管切除术患者(开放术组)的手术时间、出血量、肿瘤学预后等指标进行比较。结果:腹腔镜组患者经术后病理检查,肾盂癌24例,输尿管癌10例,输尿管癌伴膀胱癌3例,其中腹腔镜组和开放组淋巴结转移各1例。同时研究发现:①腹腔镜组与开放术组比较,手术时间缩短,出血量明显减少,术后肠胃功能恢复快,术后住院时间短,差异有统计学意义(P0.05);②两种术式肿瘤学预后在远处转移方面,腹腔镜组更少,差异有统计学意义(P0.05)。结论:后腹腔镜下肾输尿管全长切除加经尿道膀胱袖状切除并腹膜后肾周区域淋巴结清扫治疗UUT-TCC具有创伤小、痛苦少、术后恢复快等优点,可能有更好的肿瘤学预后。     

荔湾区2010～2013年艾滋病自愿咨询检测结果及影响因素分析

目的探讨艾滋病自愿咨询人群血清学检测结果及其影响因素,为荔湾区今后更好的开展VCT服务提供依据。方法以2010~2013年在荔湾区各VCT门诊接受VCT服务并登记上报的求询者作为研究对象,按照《全国艾滋病检测技术规范(2009)》要求开展HIV抗体初筛检测,阳性标本合做梅毒、丙肝、乙肝检测。采用非条件Logistic回归分析影响艾滋病自愿咨询人群艾滋病感染的相关因素。结果共调查艾滋病自愿咨询检测者6 423人,其中男性2 787人,占43.4%,女性3 636人,占56.6%;年龄集中在(32.4±10.8)岁。HIV抗体阳性98例,占1.5%,其中1例同时呈HIV、梅毒、丙肝、乙肝阳性,合并四重感染率为1%;HIV、丙肝合并感染者有42例,双重感染率为42.9%;HIV、梅毒合并感染有20例,双重感染率为20.4%;HIV、乙肝合并感染有8例,双重感染率为8.16%。经Logistic回归分析显示:对艾滋病自愿咨询检测人群艾滋病感染的影响因素是年龄、职业和人群特征。年龄段在21~60岁,吸毒者、同性恋、阳性配偶者为艾滋病感染的风险人群。结论政府组织与各部门共同担责,改进并完善自愿咨询检测服务,加强对艾滋病感染风险人群检测,向"零"艾滋迈进。     

Surgical Treatment of Annuloaortic Ectasia with Composite Grafts Including Homologous Dura Mater Valves

We describe 3 patients in whom a composite dura mater valve-Dacron tube graft was used for replacement of the entire ascending aorta and aortic valve. Two patients had Marfan's syndrome and 1, a chronic aortic dissection, type II. All had severe aortic regurgitation. There were no early or late deaths in a follow-up period of 2, 7, and 12 months, respectively. All 3 patients were asymptomatic when last seen. Two underwent postoperative aortography that disclosed well-functioning valves and good filling of the coronary arteries.It is concluded that annuloaortic ectasia is best treated by the technique of total replacement of the ascending aorta and aortic valve by a composite valve-tube graft, and that the homologous dura mater valve, for its characteristics of central flow, lack of need for anticoagulants, and durability, represents a reasonable alternative for use in this situation.     

附子酸性多糖提高免疫低下小鼠免疫功能的实验研究

目的观察附子酸性多糖对环磷酰胺所致免疫低下小鼠免疫功能的影响。方法采用植物化学方法得到附子酸性多糖,以灌胃和腹腔注射2种方式给药,观察免疫低下小鼠的胸腺、脾脏指数,腹腔巨噬细胞吞噬功能,血清溶血素,淋巴细胞转化率,自然杀伤细胞活性以及外周血白细胞计数等多项指标,与对照组比较评价附子酸性多糖对免疫低下小鼠细胞和体液免疫功能的影响。结果附子酸性多糖可显著提高正常小鼠和免疫低下小鼠的脾脏和胸腺指数,提高小鼠的腹腔巨噬细胞吞噬功能和抗体产生能力,促进淋巴细胞增殖,增强自然杀伤细胞活性,并且可以显著提高白细胞数量(P<0.05或P<0.01)。腹腔注射较灌胃给药的效果更为明显(P<0.01)。结论附子酸性多糖可以显著提高免疫低下小鼠体液免疫和细胞免疫功能,并可减轻由于环磷酰胺引起的白细胞降低,具有减轻化疗药的毒副作用。且不同给药途径可影响其疗效。附子酸性多糖具有广阔的开发应用前景。     

Early and late components of error monitoring in violent offenders with psychopathy

BACKGROUND: One of the most recognizable features of psychopathy is the reduced ability to successfully learn and adapt overt behavior. This might be due to deficient processing of error information indicating the need to adapt controlled behavior. METHODS: Event-related potentials (ERPs) and behavioral components of error-monitoring processes were investigated in 16 individuals with psychopathy and in 18 healthy subjects. A letter version of the Eriksen flanker task was used in two conditions. The first condition (normal condition) required participants to press one of two buttons depending on the identity of the target stimulus. The second condition (signaling condition) required them to signal each time they had committed an error by making a second press on a signaling button. Early stages of error monitoring were investigated by using the error-related negativity (ERN/Ne) and post-error slowing as indexes. Later stages were explored by examining the error positivity (Pe) and signaling rates. RESULTS: Both groups showed similar ERN amplitudes and amounts of post-error slowing. The psychopathic group exhibited both reduced Pe amplitudes and diminished error-signaling rates compared with the control group. CONCLUSIONS: Individuals with psychopathy show intact early error processing and automatic behavioral adaptation but have deficits in later stages of error processing and controlled behavioral adaptation. This is an indication that individuals with psychopathy are unable to effectively use error information to change their behavior adequately.     

Pathomechanism and Management of Stroke in COVID-19: Review of Immunopathogenesis,Coagulopathy, Endothelial Dysfunction,and Downregulation of ACE2

Coronavirus disease 2019 (COVID-19) can reportedly manifest as an acute stroke, with most cases presenting as large vessel ischemic stroke in patients with or without comorbidities. The exact pathomechanism of stroke in COVID-19 remains ambiguous. The findings of previous studies indicate that the most likely underlying mechanisms are cerebrovascular pathological conditions following viral infection, inflammation-induced endothelial dysfunction, and hypercoagulability. Acute endothelial damage due to inflammation triggers a coagulation cascade, thrombosis propagation, and destabilization of atherosclerosis plaques, leading to large-vessel occlusion and plaque ulceration with concomitant thromboemboli, and manifests as ischemic stroke. Another possible mechanism is the downregulation of angiotensin-converting enzyme 2 as the target action of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). Acute stroke management protocols need to be modified during the COVID-19 pandemic in order to adequately manage stroke patients with COVID-19.